Margaret is a co-founder of the Penn Society for Psychedelic Science and a co-founder and co-organizer of the Intercollegiate Psychedelics Summit, an annual conference for the convergence of university-affiliated individuals, hosted at Penn and Harvard in its first two years. She is also a co-founder and is on the executive team of the Intercollegiate Psychedelics Network, a network of 20 universities internationally that aims to reduce suffering through empowering students in psychedelic research, advocacy, and clinical interventions. She is a nonprofit advisor to the SoundMind Clinic, which offers psychedelic therapy to individuals in populations disproportionately affected by trauma. She is also is on a small team of volunteers who run Dharma Gates, a nonprofit that brings deep meditation practice to young adults. Margaret works in nonprofit consulting and holds an undergraduate degree from Cornell University and a master’s degree from the University of Pennsylvania
Victor is a PhD candidate in the Department of Bioengineering at the University of Pennsylvania. His research is focused on developing 3D tissue-engineered test beds for psychedelic compounds, as well as assessing the therapeutic potential of psychedelics in reducing chronic inflammation in traumatic brain injury. He is a co-founder of the Penn Society for Psychedelic Science and the Intercollegiate Psychedelics Summit, an annual conference for the convergence of university-affiliated individuals. He is also a co-founder and is on the executive team of the Intercollegiate Psychedelics Network, an international network of 20 universities aiming to reduce suffering through empowering students in psychedelic research, advocacy, and clinical practice.
David Wood is lawyer, patent agent and partner at Borden Ladner Gervais LLP, Canada’s largest national law firm. David is Co-Chair of BLG’s Cannabis Industry Focus Group, and practices intellectual property and regulatory law. His regulatory practice is specific to the Canadian cannabis industry, and to research and commercialization of psychedelics, entheogens and entactogens. His intellectual property practice is also largely focused on the technical fields of cannabis, psychedelics, entheogens, entactogens and medical devices. David holds a PhD in biochemistry. His graduate-level education in structural biochemistry, organic chemistry, physical chemistry, plant biochemistry, and natural products chemistry provides a strong technical background for advising clients in the Canadian cannabis industry, and clients positioning for commercialization of psychedelics, entheogens and entactogens, in relation to both intellectual property and regulatory law
Carmen Jackman is a native Marylander, born in Washington D.C., and raised in Silver Spring, MD. She is the Founder and Content Manager at Butwhatabout.net and is in the UX Design M.P.S. program at the Maryland Institute College of Art (MICA). In 2012 she received a B.A. in History from the University of Maryland Baltimore County. Carmen is currently the Intersectionality Committee Co-Chair for Students for Sensible Drug Policy (SSDP) and also manages the D.C Psychedelic Society's social media. Oriana Mayorga is a born and raised New Yorker, artist, anti-racist organizer and seminary student at Union Theological Seminary. Currently, she serves as the Vice Chair of the Board of Directors for Students for Sensible Drug Policy (SSDP), she also Co-chairs the Intersectionality Committee and is the social media manager for her Columbia University chapter. Oriana published her psychedelic research while studying Psychology at Fordham University in 2014 and received a Graduate certificate in Harm Reduction Psychotherapy from The New School in 2016.
As husband-and-wife founders of the Oregon Psilocybin Society and architects of Oregon’s Psilocybin Therapy Ballot Initiative, Tom and Sheri Eckert have set in motion a clear vision to integrate psychedelic therapy into the culture. Their campaign has attracted a powerful global coalition of supporters. The Eckert’s are also seasoned therapists and program directors who serve the Portland metro area.
Kevin Matthews is the Co-Founder & Executive Director for the non-profit Society for Psychedelic Outreach, Reform, and Education (SPORE). He wokred with the Denver Psilocybin Initiative to become the first city to decriminalize psilocybin, and continues to support psychedelic outreach, education, and reform.
Robert W.E. Laurie is an international lawyer, qualified in England and called to the British Columbia Bar. Robert founded AD LUCEM LAW CORPORATION in Vancouver in 2013 and his legal practice focuses on commercial business, government, regulatory issues, plus Charter and constitutional legalities surrounding cannabis and psychedelic plant medicines. Robert serves as a Board Advisor to the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada, Steve DeAngelo’s Last Prisoner Project, SPORE Denver and is Legal Advisor to the Heroic Hearts Project UK. Robert is one of the Founding Partners with Dr. Dennis McKenna of the McKenna Academy of Natural Philosophy. He serves as a Director with Jay DeMerit and Ashleigh McIvor’s Rise and Shine Foundation and Rex Weyler’s Ecuador Amazon Restoration Project. Robert holds an M.A. (Hons) Juris from the University of Oxford (St. Edmund Hall) and B.A. (Hons) in Political Science and International Relations from the University of British Columbia.
William Goss studied, researched,foraged, and cultivated fungi for over 10 years. He studied under and was mentored by leading mycologists Dr. Mike Davis, and Dr. Thomas Gordon, Department Chair of Plant Pathology. He graduated from UC Davis with a degree in plant genetics, and a minor in mycology. He was grower supervisor and the water Systems operator for Monterey Mushrooms at the continents largest organic mushroom farm. William implemented best practices for maximizing fungal cultivation while scaling a biotech start-up, growing and processing mushroom mycelium, disrupting the conventional leather industry. He is currently the Mycology Director for the California Psilocybin Decriminalization Initiative. Available for strategic planning and consultation in the following key areas: drug policy reform, best practices for laboratory management, scaling production operations, maximizing fungal growth, nutrient cycle optimization, experimental design and implementation, evaluating mushroom biochemical properties for pharmaceutical and therapeutic potentials.
Jesse Hudson is an anthropologist and attorney working in the psychedelic space since 2007. He is a member of the Chacruna Council for Protection of Sacred Plants, board member at Sage Institute for Psychedelic Therapy, advisor to Enthea Health, and mentor in the SSDP Psychedelic Pipeline. He has worked with the Matsigenga and the Shipibo-Conibo tribes in the Peruvian Amazon, published peer-reviewed papers on the legal frameworks for psychedelics, and counseled several psychedelic-assisted therapy clinics. He helped ICEERS launch and develop the Ayahuasca Defense Fund. And co-authored annual ESG and CSR benchmarkings of thousands of companies with Development International. Jesse has a BA magna cum laude from the University of Colorado, Boulder and a JD/MS from Tulane Law School.
Natthan Davis is an entrepreneur that was a part of his first venture in 2014 with Hotbox.farm, Canada’s first mobile cannabis grow op. He worked within the underground industry first hand supplying cultivators with LED grow lights seeing the growth and inner workings of the grey market dispensary landscape. He is now researching the mushroom dispensary industry trying to make sense of the murky water ahead.
Jonathan Dickinson is a counselor and consultant who has been working with iboga and ibogaine in both clinical and ceremonial contexts in Canada, Mexico, and Costa Rica since 2009. He currently resides in Tijuana, Mexico and has a private practice called Ceiba Ibogaine Therapy supporting people through the ibogaine treatment process. He previously served as the Director of the Global Ibogaine Therapy Alliance (GITA), during which time he led the development of the Clinical Guidelines for Ibogaine-Assisted Detoxification, a risk management guide that remains a standard in the field. He organized several conferences on ibogaine therapy practice and safety protocols, and has collaborated with researchers in multiple disciplines, publishing peer reviewed work and presenting at numerous conferences internationally. In 2014, Jonathan was initiated into a Dissoumba/Fang tradition of Bwiti in Gabon, and remains actively involved with both clinical and ceremonial approaches.
Cofounder of Ibogaine Research Institute, Ashley is a forward-thinking operator with a history of running large corporations that bring the strength of a stable foundation for systems to businesses. With a background in arts, she values higher purpose, and has experienced firsthand the importance of wellness programs, mental health support, and integration therapy for the true future of success: higher consciousness. Ashley and Ibogaine Research Institute are launching Iboguide.me -- a safe resource for the public to aid in decision making for the growing demand in ibogaine treatments and aftercare.Having been given a new direction in life as a result of ibogaine and post integrative therapy in 2010, Talia has become a passionate advocate for both people and planet. She has a proven track record as a successful entrepreneur and operations leader of a venture backed startup, Henley LLC, which helped disrupt big tobacco. Most recently, backed by HTC, Talia developed a VR mindfulness application for stress reduction in corporate settings. Talia is a heart-based, outside of the box, strategic thinker with a vast understanding of the holistic wellness industry. Talia received her Master certification as a practitioner of Energy Medicine in 2017; her work has appeared in the Huffington Post, New York Times, and Wall Street Journal.
Simeon is a life-long student of Psychedelics and has a keen awareness of the cultural regulatory and the nascent venture landscape of the mushrooming industry. He has traveled the globe participating in psychedelic conferences to living with indigenous communities. He co-founded the High Art Collective in 2008 the world’s first Psychedelic Art Gallery and MMJ Dispensary praised as a paradigm shift at the very beginning of the end of prohibition. Simeon advises several psychedelic startups, is a founding partner at JLS a plant medicine fund, is an Aspen Institute Fellow and a member of NYMS (New York Mycology Society).